Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 3/2019

01.03.2019 | Cardiac Computed Tomography (B Chow and G Small, Section Editors)

Plaque Assessment on Serial Coronary CTA

verfasst von: Guilherme Monteiro, Roberto C. Cury, Marcio S. Bittencourt

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review addresses the role of serial coronary computed tomography angiography (CTA) on the evaluation of atherosclerosis progression, risk stratification, and targeting individual pharmacotherapy.

Recent Findings

The presence, extent, and severity of coronary artery disease (CAD) detected by coronary CTA are associated with an adverse prognosis. Similarly, the presence of high-risk plaque features such as positive remodeling, low-attenuation plaque, spotty calcifications, and napkin-ring sign are associated with major adverse cardiac events. More recently, examinations using serial coronary CTA have also shown that these static CTA plaque features are associated with a more rapid progression of atherosclerosis on follow-up imaging and may identify a subset of patients at increased risk for plaque rupture. While the impact of serial CTA findings on management and hard outcomes remains a topic of ongoing investigation, available data supports the ability of statin therapy to reduce CTA-identified plaque burden and modify plaque composition.

Summary

Coronary CTA identifies various plaque features associated with an increased risk of plaque progression and adverse cardiac events. Available data support the use of CTA to individualize statin therapy and utilize serial CTA imaging to study the impact of pharmacotherapy on plaque burden and outcomes.
Literatur
1.
Zurück zum Zitat Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262–75.CrossRef Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262–75.CrossRef
2.
Zurück zum Zitat Sandfort V, Lima JA, Bluemke DA. Noninvasive imaging of atherosclerotic plaque progression: status of coronary computed tomography angiography. Circ Cardiovasc Imaging. 2015;8:e003316.CrossRef Sandfort V, Lima JA, Bluemke DA. Noninvasive imaging of atherosclerotic plaque progression: status of coronary computed tomography angiography. Circ Cardiovasc Imaging. 2015;8:e003316.CrossRef
3.
Zurück zum Zitat • Bittencourt MS, Hulten E, Ghoshhajra B, O’Leary D, Christman MP, Montana P, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014;7:282–91 This study illustrated the prognostic value of atherosclerotic burden in individuals with nonobstructive and obstructive CAD detected by coronary CTA. CrossRef • Bittencourt MS, Hulten E, Ghoshhajra B, O’Leary D, Christman MP, Montana P, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014;7:282–91 This study illustrated the prognostic value of atherosclerotic burden in individuals with nonobstructive and obstructive CAD detected by coronary CTA. CrossRef
4.
Zurück zum Zitat • Ahmadi A, Leipsic J, Blankstein R, Taylor C, Hecht H, Stone GW, et al. Do plaques rapidly progress prior to myocardial infarction?: the interplay between plaque vulnerability and progression. Circ Res. 2015;117:99–104 This study provides data supporting the idea that atherosclerotic plaques tend to progress to obstructive disease prior to acute coronary syndrome. CrossRef • Ahmadi A, Leipsic J, Blankstein R, Taylor C, Hecht H, Stone GW, et al. Do plaques rapidly progress prior to myocardial infarction?: the interplay between plaque vulnerability and progression. Circ Res. 2015;117:99–104 This study provides data supporting the idea that atherosclerotic plaques tend to progress to obstructive disease prior to acute coronary syndrome. CrossRef
5.
Zurück zum Zitat Weintraub WS. Relation of angiographic and ultrasound assessment of plaque progression to clinical outcomes. Am J Cardiol. 1998;81:69f–72f.CrossRef Weintraub WS. Relation of angiographic and ultrasound assessment of plaque progression to clinical outcomes. Am J Cardiol. 1998;81:69f–72f.CrossRef
6.
Zurück zum Zitat Achenbach S, Ulzheimer S, Baum U, Kachelriess M, Ropers D, Giesler T, et al. Noninvasive coronary angiography by retrospectively ECG-gated multislice spiral CT. Circulation. 2000;102:2823–8.CrossRef Achenbach S, Ulzheimer S, Baum U, Kachelriess M, Ropers D, Giesler T, et al. Noninvasive coronary angiography by retrospectively ECG-gated multislice spiral CT. Circulation. 2000;102:2823–8.CrossRef
7.
Zurück zum Zitat de Graaf FR, van Velzen JE, de Boer SM, van Werkhoven JM, Kroft LJ, de Roos A, et al. Non-invasive computed tomography coronary angiography as a gatekeeper for invasive coronary angiography. Int J Cardiovasc Imaging. 2013;29:221–8.CrossRef de Graaf FR, van Velzen JE, de Boer SM, van Werkhoven JM, Kroft LJ, de Roos A, et al. Non-invasive computed tomography coronary angiography as a gatekeeper for invasive coronary angiography. Int J Cardiovasc Imaging. 2013;29:221–8.CrossRef
8.
Zurück zum Zitat Butler J, Shapiro M, Reiber J, Sheth T, Ferencik M, Kurtz EG, et al. Extent and distribution of coronary artery disease: a comparative study of invasive versus noninvasive angiography with computed angiography. Am Heart J. 2007;153:378–84.CrossRef Butler J, Shapiro M, Reiber J, Sheth T, Ferencik M, Kurtz EG, et al. Extent and distribution of coronary artery disease: a comparative study of invasive versus noninvasive angiography with computed angiography. Am Heart J. 2007;153:378–84.CrossRef
9.
Zurück zum Zitat Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009;3:122–36.CrossRef Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009;3:122–36.CrossRef
10.
Zurück zum Zitat • Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, et al. CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr. 2016;10:269–81 This is the official recommendation for structured reporting of CAD in coronary CTA. CrossRef • Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, et al. CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr. 2016;10:269–81 This is the official recommendation for structured reporting of CAD in coronary CTA. CrossRef
11.
Zurück zum Zitat Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974;34:48–55.CrossRef Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974;34:48–55.CrossRef
12.
Zurück zum Zitat • Hulten EA, Carbonaro S, Petrillo SP, Mitchell JD, Villines TC. Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;57:1237–47 This meta-analysis provides detailed data on the prognostic value of the presence and severity of CAD detected on coronary CTA. CrossRef • Hulten EA, Carbonaro S, Petrillo SP, Mitchell JD, Villines TC. Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;57:1237–47 This meta-analysis provides detailed data on the prognostic value of the presence and severity of CAD detected on coronary CTA. CrossRef
13.
Zurück zum Zitat Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50:1161–70.CrossRef Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50:1161–70.CrossRef
14.
Zurück zum Zitat Mock MB, Ringqvist I, Fisher LD, Davis KB, Chaitman BR, Kouchoukos NT, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation. 1982;66:562–8.CrossRef Mock MB, Ringqvist I, Fisher LD, Davis KB, Chaitman BR, Kouchoukos NT, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation. 1982;66:562–8.CrossRef
19.
Zurück zum Zitat Shah NR, Cheezum MK, Motoyama S, Chatzizisis YS. Do we really need another individual coronary plaque characterization measurement? Atherosclerosis. 2017;261:160–2.CrossRef Shah NR, Cheezum MK, Motoyama S, Chatzizisis YS. Do we really need another individual coronary plaque characterization measurement? Atherosclerosis. 2017;261:160–2.CrossRef
15.
Zurück zum Zitat Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312:1754–63.CrossRef Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312:1754–63.CrossRef
16.
Zurück zum Zitat Hadamitzky M, Taubert S, Deseive S, Byrne RA, Martinoff S, Schomig A, et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur Heart J. 2013;34:3277–85.CrossRef Hadamitzky M, Taubert S, Deseive S, Byrne RA, Martinoff S, Schomig A, et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur Heart J. 2013;34:3277–85.CrossRef
17.
Zurück zum Zitat Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58:849–60.CrossRef Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58:849–60.CrossRef
18.
Zurück zum Zitat Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13–8.CrossRef Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13–8.CrossRef
20.
Zurück zum Zitat Motoyama S, Ito H, Sarai M, Kondo T, Kawai H, Nagahara Y, et al. Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol. 2015;66:337–46.CrossRef Motoyama S, Ito H, Sarai M, Kondo T, Kawai H, Nagahara Y, et al. Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol. 2015;66:337–46.CrossRef
21.
Zurück zum Zitat •• Maldonado N, Kelly-Arnold A, Cardoso L, Weinbaum S. The explosive growth of small voids in vulnerable cap rupture; cavitation and interfacial debonding. J Biomech. 2013;46:396–401 This is the first study to define low-attenuation plaque, positive remodeling, and spotty calcifications as markers of prognosis in coronary CTA. CrossRef •• Maldonado N, Kelly-Arnold A, Cardoso L, Weinbaum S. The explosive growth of small voids in vulnerable cap rupture; cavitation and interfacial debonding. J Biomech. 2013;46:396–401 This is the first study to define low-attenuation plaque, positive remodeling, and spotty calcifications as markers of prognosis in coronary CTA. CrossRef
22.
Zurück zum Zitat Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49–57.CrossRef Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49–57.CrossRef
23.
Zurück zum Zitat van Velzen JE, de Graaf FR, de Graaf MA, Schuijf JD, Kroft LJ, de Roos A, et al. Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis. J Nucl Cardiol. 2011;18:893–903.CrossRef van Velzen JE, de Graaf FR, de Graaf MA, Schuijf JD, Kroft LJ, de Roos A, et al. Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis. J Nucl Cardiol. 2011;18:893–903.CrossRef
24.
Zurück zum Zitat Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary-arteries. New Engl J Med. 1987;316:1371–5.CrossRef Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary-arteries. New Engl J Med. 1987;316:1371–5.CrossRef
25.
Zurück zum Zitat •• Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50:319–26 This study has defined the napkin-ring sign as a marker of increased risk in coronary CTA. CrossRef •• Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50:319–26 This study has defined the napkin-ring sign as a marker of increased risk in coronary CTA. CrossRef
26.
Zurück zum Zitat Maurovich-Horvat P, Hoffmann U, Vorpahl M, Nakano M, Virmani R, Alkadhi H. The napkin-ring sign: CT signature of high-risk coronary plaques? J Am Coll Cardiol Img. 2010;3:440–4.CrossRef Maurovich-Horvat P, Hoffmann U, Vorpahl M, Nakano M, Virmani R, Alkadhi H. The napkin-ring sign: CT signature of high-risk coronary plaques? J Am Coll Cardiol Img. 2010;3:440–4.CrossRef
27.
Zurück zum Zitat •• Nadjiri J, Hausleiter J, Jahnichen C, Will A, Hendrich E, Martinoff S, et al. Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up. J Cardiovasc Comput Tomogr. 2016;10:97–104 This is the largest study to date evaluating the impact of atherosclerosis progression on coronary CTA and its impacts on prognosis. CrossRef •• Nadjiri J, Hausleiter J, Jahnichen C, Will A, Hendrich E, Martinoff S, et al. Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up. J Cardiovasc Comput Tomogr. 2016;10:97–104 This is the largest study to date evaluating the impact of atherosclerosis progression on coronary CTA and its impacts on prognosis. CrossRef
28.
Zurück zum Zitat Feuchtner G, Kerber J, Burghard P, Dichtl W, Friedrich G, Bonaros N, et al. The high-risk criteria low-attenuation plaque <60 HU and the napkin-ring sign are the most powerful predictors of MACE: a long-term follow-up study. Eur Heart J Cardiovasc Imaging. 2017;18:772–9.CrossRef Feuchtner G, Kerber J, Burghard P, Dichtl W, Friedrich G, Bonaros N, et al. The high-risk criteria low-attenuation plaque <60 HU and the napkin-ring sign are the most powerful predictors of MACE: a long-term follow-up study. Eur Heart J Cardiovasc Imaging. 2017;18:772–9.CrossRef
29.
Zurück zum Zitat Budoff MJ, Raggi P. Coronary artery disease progression assessed by electron-beam computed tomography. Am J Cardiol. 2001;88:46–50.CrossRef Budoff MJ, Raggi P. Coronary artery disease progression assessed by electron-beam computed tomography. Am J Cardiol. 2001;88:46–50.CrossRef
30.
Zurück zum Zitat Bertrand OF, Poirier P, Rodes-Cabau J, Rinfret S, Title L, Dzavik V, et al. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. Can J Cardiol. 2009;25:509–15.CrossRef Bertrand OF, Poirier P, Rodes-Cabau J, Rinfret S, Title L, Dzavik V, et al. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. Can J Cardiol. 2009;25:509–15.CrossRef
31.
Zurück zum Zitat Fayad ZA, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J, et al. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Am Heart J. 2011;162:214–221.e2.CrossRef Fayad ZA, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J, et al. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Am Heart J. 2011;162:214–221.e2.CrossRef
32.
Zurück zum Zitat Budoff M, Brent Muhlestein J, Le VT, May HT, Roy S, Nelson JR. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: rationale and design of the EVAPORATE study. Clin Cardiol. 2018;41:13–9.CrossRef Budoff M, Brent Muhlestein J, Le VT, May HT, Roy S, Nelson JR. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: rationale and design of the EVAPORATE study. Clin Cardiol. 2018;41:13–9.CrossRef
33.
Zurück zum Zitat Osawa K, Nakanishi R, Win TT, Li D, Rahmani S, Nezarat N, et al. Rationale and design of a randomized trial of apixaban vs warfarin to evaluate atherosclerotic calcification and vulnerable plaque progression. Clin Cardiol. 2017;40:807–13.CrossRef Osawa K, Nakanishi R, Win TT, Li D, Rahmani S, Nezarat N, et al. Rationale and design of a randomized trial of apixaban vs warfarin to evaluate atherosclerotic calcification and vulnerable plaque progression. Clin Cardiol. 2017;40:807–13.CrossRef
34.
Zurück zum Zitat Nakanishi R, Post WS, Osawa K, Jayawardena E, Kim M, Sheidaee N, et al. Multicenter AIDS cohort study quantitative coronary plaque progression study: rationale and design. Coron Artery Dis. 2018;29:23–9.PubMedPubMedCentral Nakanishi R, Post WS, Osawa K, Jayawardena E, Kim M, Sheidaee N, et al. Multicenter AIDS cohort study quantitative coronary plaque progression study: rationale and design. Coron Artery Dis. 2018;29:23–9.PubMedPubMedCentral
43.
Zurück zum Zitat Lehman SJ, Schlett CL, Bamberg F, Lee H, Donnelly P, Shturman L, et al. Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score. J Am Coll Cardiol Img. 2009;2:1262–70.CrossRef Lehman SJ, Schlett CL, Bamberg F, Lee H, Donnelly P, Shturman L, et al. Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score. J Am Coll Cardiol Img. 2009;2:1262–70.CrossRef
44.
Zurück zum Zitat Imai A, Komatsu S, Ohara T, Kamata T, Yoshida J, Miyaji K, et al. Visceral abdominal fat accumulation predicts the progression of noncalcified coronary plaque. Atherosclerosis. 2012;222:524–9.CrossRef Imai A, Komatsu S, Ohara T, Kamata T, Yoshida J, Miyaji K, et al. Visceral abdominal fat accumulation predicts the progression of noncalcified coronary plaque. Atherosclerosis. 2012;222:524–9.CrossRef
45.
Zurück zum Zitat Ayad SW, ElSharkawy EM, ElTahan SM, Sobhy MA, Laymouna RH. The role of 64/128-slice multidetector computed tomography to assess the progression of coronary atherosclerosis. Clin Med Insights Cardiol. 2015;9:47–52.CrossRef Ayad SW, ElSharkawy EM, ElTahan SM, Sobhy MA, Laymouna RH. The role of 64/128-slice multidetector computed tomography to assess the progression of coronary atherosclerosis. Clin Med Insights Cardiol. 2015;9:47–52.CrossRef
35.
Zurück zum Zitat Psaltis PJ, Talman AH, Munnur K, Cameron JD, Ko BS, Meredith IT, et al. Relationship between epicardial fat and quantitative coronary artery plaque progression: insights from computer tomography coronary angiography. Int J Cardiovasc Imaging. 2016;32:317–28.CrossRef Psaltis PJ, Talman AH, Munnur K, Cameron JD, Ko BS, Meredith IT, et al. Relationship between epicardial fat and quantitative coronary artery plaque progression: insights from computer tomography coronary angiography. Int J Cardiovasc Imaging. 2016;32:317–28.CrossRef
46.
Zurück zum Zitat Sakellarios A, Bourantas CV, Papadopoulou SL, Tsirka Z, de Vries T, Kitslaar PH, et al. Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study. Eur Heart J Cardiovasc Imaging. 2017;18:11–8.CrossRef Sakellarios A, Bourantas CV, Papadopoulou SL, Tsirka Z, de Vries T, Kitslaar PH, et al. Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study. Eur Heart J Cardiovasc Imaging. 2017;18:11–8.CrossRef
47.
Zurück zum Zitat Nakanishi R, Ceponiene I, Osawa K, Luo Y, Kanisawa M, Megowan N, et al. Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: a propensity-score matching study. Atherosclerosis. 2016;255:73–9.CrossRef Nakanishi R, Ceponiene I, Osawa K, Luo Y, Kanisawa M, Megowan N, et al. Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: a propensity-score matching study. Atherosclerosis. 2016;255:73–9.CrossRef
48.
Zurück zum Zitat Tan Y, Zhou J, Zhou Y, Yang X, Wang J, Chen Y. Epicardial adipose tissue is associated with high-risk plaque feature progression in non-culprit lesions. Int J Cardiovasc Imaging. 2017;33:2029–37.CrossRef Tan Y, Zhou J, Zhou Y, Yang X, Wang J, Chen Y. Epicardial adipose tissue is associated with high-risk plaque feature progression in non-culprit lesions. Int J Cardiovasc Imaging. 2017;33:2029–37.CrossRef
49.
Zurück zum Zitat Suzuki T, Nozawa T, Fujii N, Sobajima M, Ohori T, Shida T, et al. Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease. Coron Artery Dis. 2011;22:352–8.CrossRef Suzuki T, Nozawa T, Fujii N, Sobajima M, Ohori T, Shida T, et al. Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease. Coron Artery Dis. 2011;22:352–8.CrossRef
36.
Zurück zum Zitat Zeb I, Li D, Nasir K, Malpeso J, Batool A, Flores F, et al. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study. Atherosclerosis. 2013;231:198–204.CrossRef Zeb I, Li D, Nasir K, Malpeso J, Batool A, Flores F, et al. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study. Atherosclerosis. 2013;231:198–204.CrossRef
50.
Zurück zum Zitat Li Z, Hou Z, Yin W, Liu K, Gao Y, Xu H, et al. Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: a multicenter prospective study. Am Heart J. 2016;180:29–38.CrossRef Li Z, Hou Z, Yin W, Liu K, Gao Y, Xu H, et al. Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: a multicenter prospective study. Am Heart J. 2016;180:29–38.CrossRef
37.
Zurück zum Zitat Shin S, Park HB, Chang HJ, Arsanjani R, Min JK, Kim YJ, et al. Impact of intensive LDL cholesterol lowering on coronary artery atherosclerosis progression: a serial CT angiography study. J Am Coll Cardiol Img. 2017;10:437–46.CrossRef Shin S, Park HB, Chang HJ, Arsanjani R, Min JK, Kim YJ, et al. Impact of intensive LDL cholesterol lowering on coronary artery atherosclerosis progression: a serial CT angiography study. J Am Coll Cardiol Img. 2017;10:437–46.CrossRef
51.
Zurück zum Zitat Matsumoto S, Ibrahim R, Gregoire JC, L'Allier PL, Pressacco J, Tardif JC, et al. Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study. Clin Cardiol. 2017;40:210–5.CrossRef Matsumoto S, Ibrahim R, Gregoire JC, L'Allier PL, Pressacco J, Tardif JC, et al. Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study. Clin Cardiol. 2017;40:210–5.CrossRef
38.
Zurück zum Zitat Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, et al. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lancet HIV. 2015;2:e52–63.CrossRef Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, et al. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lancet HIV. 2015;2:e52–63.CrossRef
40.
Zurück zum Zitat Lee SE, Chang HJ, Sung JM, Park HB, Heo R, Rizvi A, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. J Am Coll Cardiol Img. 2018;11:1475–84.CrossRef Lee SE, Chang HJ, Sung JM, Park HB, Heo R, Rizvi A, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. J Am Coll Cardiol Img. 2018;11:1475–84.CrossRef
39.
Zurück zum Zitat Lee SE, Chang HJ, Rizvi A, Hadamitzky M, Kim YJ, Conte E, et al. Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: a comprehensive exploration of plaque progression and its impact on clinical outcomes from a multicenter serial coronary computed tomographic angiography study. Am Heart J. 2016;182:72–9.CrossRef Lee SE, Chang HJ, Rizvi A, Hadamitzky M, Kim YJ, Conte E, et al. Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: a comprehensive exploration of plaque progression and its impact on clinical outcomes from a multicenter serial coronary computed tomographic angiography study. Am Heart J. 2016;182:72–9.CrossRef
52.
Zurück zum Zitat Tan Y, Zhou J, Zhou Y, Yang X, Yang J, Chen Y. Characteristics detected on computed tomography angiography predict coronary artery plaque progression in non-culprit lesions. Korean J Radiol. 2017;18:487–97.CrossRef Tan Y, Zhou J, Zhou Y, Yang X, Yang J, Chen Y. Characteristics detected on computed tomography angiography predict coronary artery plaque progression in non-culprit lesions. Korean J Radiol. 2017;18:487–97.CrossRef
53.
Zurück zum Zitat Gu H, Gao Y, Wang H, Hou Z, Han L, Wang X, et al. Sex differences in coronary atherosclerosis progression and major adverse cardiac events in patients with suspected coronary artery disease. J Cardiovasc Comput Tomogr. 2017;11:367–72.CrossRef Gu H, Gao Y, Wang H, Hou Z, Han L, Wang X, et al. Sex differences in coronary atherosclerosis progression and major adverse cardiac events in patients with suspected coronary artery disease. J Cardiovasc Comput Tomogr. 2017;11:367–72.CrossRef
54.
Zurück zum Zitat Gu H, Gao Y, Hou Z, Schoepf UJ, Snyder AN, Duguay TM, et al. Prognostic value of coronary atherosclerosis progression evaluated by coronary CT angiography in patients with stable angina. Eur Radiol. 2018;28:1066–76.CrossRef Gu H, Gao Y, Hou Z, Schoepf UJ, Snyder AN, Duguay TM, et al. Prognostic value of coronary atherosclerosis progression evaluated by coronary CT angiography in patients with stable angina. Eur Radiol. 2018;28:1066–76.CrossRef
41.
Zurück zum Zitat Lee SE, Sung JM, Rizvi A, Lin FY, Kumar A, Hadamitzky M, et al. Quantification of coronary atherosclerosis in the assessment of coronary artery disease. Circ Cardiovasc Imaging. 2018;11:e007562.CrossRef Lee SE, Sung JM, Rizvi A, Lin FY, Kumar A, Hadamitzky M, et al. Quantification of coronary atherosclerosis in the assessment of coronary artery disease. Circ Cardiovasc Imaging. 2018;11:e007562.CrossRef
42.
Zurück zum Zitat Ito H, Motoyama S, Sarai M, Kawai H, Harigaya H, Kan S, et al. Characteristics of plaque progression detected by serial coronary computed tomography angiography. Heart Vessel. 2014;29:743–9.CrossRef Ito H, Motoyama S, Sarai M, Kawai H, Harigaya H, Kan S, et al. Characteristics of plaque progression detected by serial coronary computed tomography angiography. Heart Vessel. 2014;29:743–9.CrossRef
Metadaten
Titel
Plaque Assessment on Serial Coronary CTA
verfasst von
Guilherme Monteiro
Roberto C. Cury
Marcio S. Bittencourt
Publikationsdatum
01.03.2019
Verlag
Springer US
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 3/2019
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-019-9483-7

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.